James E. Flynn - Possible Members of 10% Group, 10%+ Owner at Bicara Therapeutics Inc.

Issuer-level insider activity

Role
Possible Members of 10% Group, 10%+ Owner
Issuer symbol
BCAX on Nasdaq
Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by James E. Flynn since 03 Jun 2025

Reported holdings for James E. Flynn in Bicara Therapeutics Inc.

Form 4 holding Possible Members of 10% Group, 10%+ Owner

Bicara Therapeutics Inc.

Security class
Common Stock
Shares / value
897,587
Estimated value
$11,887,104
Report date
17 Sep 2024
Price
$13.24
Ownership
Through Deerfield Partners, L.P.
Form 4 holding Possible Members of 10% Group, 10%+ Owner

Bicara Therapeutics Inc.

Security class
Common Stock
Shares / value
897,587
Estimated value
$11,887,104
Report date
17 Sep 2024
Price
$13.24
Ownership
Through Deerfield Private Design Fund V, L.P.
Form 4 holding Possible Members of 10% Group, 10%+ Owner

Bicara Therapeutics Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
17 Sep 2024
Price
Ownership
Through Deerfield Partners, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Possible Members of 10% Group, 10%+ Owner

Bicara Therapeutics Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
17 Sep 2024
Price
Ownership
Through Deerfield Private Design Fund V, L.P.
Underlying class
Common Stock
Underlying amount

Transaction history for James E. Flynn in Bicara Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .